SCHULMAN AMY W
SEC CIK 1438226 · EDGAR
BoughtSold
Most active insiders at ALNY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Greenstreet Yvonne | CEO, Dir | — | $24.46M |
| 2 | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | — | $10.74M |
| 3 | Garg Pushkal | EVP Chief R, D | — | $8.12M |
| 4 | Poulton Jeffrey V. | EVP, CFO | — | $4.95M |
| 5 | Tanguler Tolga | EVP, Chief Commercial Off | — | $3.06M |
| 6 | McLaughlin Melissa | CHRO | — | $1.27M |
| 7 | PYOTT DAVID E I | Dir | — | $1.15M |
| 8 | Reitan Colleen F | Dir | — | — |
| 9 | Sigal Charles Elliott | Dir | — | — |
| 10 | Arbuckle Stuart A | Dir | — | — |
| 13 | SCHULMAN AMY W | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-22 16:18 | 2026-05-20 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Dir | A - Grant | $0.00 | +838 | 24.0K | +4% | $0 |
| 2026-05-15 16:16 | 2026-05-13 | ELV | Elevance Health | SCHULMAN AMY W | Dir | A - Grant | $0.00 | +563 | 781 | +258% | $0 | |
| D | 2026-05-14 16:17 | 2026-05-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Dir | M - OptEx | $70.20 | +11.2K | 23.2K | +94% | +$789.8K |
| 2026-03-23 | 2026-03-12 | ELV | Elevance Health | SCHULMAN AMY W | Dir | S - Sale | $287.50 | -26 | 218 | -11% | -$7,475 | |
| 2026-02-03 | 2026-02-02 | ELV | Elevance Health | SCHULMAN AMY W | Dir | A - Grant | $0.00 | +218 | 218 | New | $0 | |
| D | 2025-05-12 | 2025-05-08 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Dir | A - Grant | $0.00 | +775 | 12.0K | +7% | $0 |
| 2025-03-17 | 2025-03-13 | GUTS | FRACTYL HEALTH, INC. | SCHULMAN AMY W | Dir | P - Purchase | $1.17 | +8,550 | 8,550 | New | +$10.0K | |
| D | 2025-03-14 | 2025-03-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Dir | M - OptEx | $131.21 | +2,750 | 11.2K | +33% | +$360.8K |
| D | 2024-06-27 | 2024-06-25 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Dir | S - Sale+OE | $240.00 | -8,500 | 8,436 | -50% | -$2.04M |
| D | 2024-06-27 | 2024-06-25 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Dir | M - OptEx | $131.21 | +8,500 | 16.9K | +101% | +$1.12M |
| D | 2024-05-31 | 2024-05-29 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Dir | M - OptEx | $66.83 | +30.0K | 30.1K | +22,059% | +$2.00M |
| DM | 2024-05-31 | 2024-05-29 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Dir | S - Sale+OE | $148.60 | -21.7K | 20.0K | -52% | -$3.22M |
| D | 2023-02-27 | 2023-02-23 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Dir | M - OptEx | $0.00 | +136 | 136 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations